"Thromboxane B2" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A stable, physiologically active compound formed in vivo from the prostaglandin endoperoxides. It is important in the platelet-release reaction (release of ADP and serotonin).
| Descriptor ID |
D013929
|
| MeSH Number(s) |
D10.251.355.255.100.825.810 D10.251.355.310.166.971.810
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Thromboxane B2".
Below are MeSH descriptors whose meaning is more specific than "Thromboxane B2".
This graph shows the total number of publications written about "Thromboxane B2" by people in this website by year, and whether "Thromboxane B2" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 2 | 2 |
| 2000 | 1 | 0 | 1 |
| 2001 | 0 | 2 | 2 |
| 2002 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2014 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Thromboxane B2" by people in Profiles.
-
Pharmacokinetic/pharmacodynamic assessment of a novel, pharmaceutical lipid-aspirin complex: results of a randomized, crossover, bioequivalence study. J Thromb Thrombolysis. 2019 Nov; 48(4):554-562.
-
Age-related differences in urinary 11-dehydroxythromboxane B2 between infants, children, and adolescents: another example of developmental hemostasis? Pediatr Blood Cancer. 2014 Nov; 61(11):2074-6.
-
Platelet activation patterns in platelet size sub-populations: differential responses to aspirin in vitro. J Thromb Thrombolysis. 2010 Oct; 30(3):251-62.
-
An active triple-catalytic hybrid enzyme engineered by linking cyclo-oxygenase isoform-1 to prostacyclin synthase that can constantly biosynthesize prostacyclin, the vascular protector. FEBS J. 2008 Dec; 275(23):5820-9.
-
Effects of omega-3 acid ethyl esters and aspirin, alone and in combination, on platelet function in healthy subjects. Thromb Haemost. 2008 Oct; 100(4):634-41.
-
Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy. Thromb Haemost. 2008 Jul; 100(1):83-9.
-
Ciglitazone, a peroxisome proliferator-activated receptor gamma inducer, ameliorates renal preglomerular production and activity of angiotensin II and thromboxane A2 in glycerol-induced acute renal failure. J Pharmacol Exp Ther. 2007 Aug; 322(2):461-8.
-
Symptoms of posttraumatic stress disorder in patients who have had a myocardial infarction. Psychosomatics. 2006 May-Jun; 47(3):231-9.
-
Terms and conditions: semantic complexity and aspirin resistance. Circulation. 2004 Sep 21; 110(12):1706-8.
-
Primary chemoprevention of familial adenomatous polyposis with sulindac. N Engl J Med. 2002 Apr 04; 346(14):1054-9.